Skip to content

Drug interactions

Erythromycin + Pomalidomide

Severity: Minor

Erythromycin and Pomalidomide: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pomalidomide is a P-glycoprotein substrate and erythromycin inhibits P-gp, so exposure may rise slightly. The expected effect is modest and unlikely to be clinically significant in most patients.

What this interaction means in plain words

Erythromycin and Pomalidomide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Erythromycin belongs to Anti Bacterial; Pomalidomide belongs to Miscellaneous.

Evidence level: Low

Why it happens

Erythromycin inhibits P-glycoprotein efflux, which may modestly increase pomalidomide exposure.

What to do

No dose change is usually needed; monitor for hematologic toxicity as part of routine pomalidomide care.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Erythromycin and Pomalidomide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Erythromycin with Pomalidomide?

MediHelp rates the interaction as minor. Erythromycin and Pomalidomide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Pomalidomide is a P-glycoprotein substrate and erythromycin inhibits P-gp, so exposure may rise slightly. The expected effect is modest and unlikely to be clinically significant in most patients.

How serious is the interaction between Erythromycin and Pomalidomide?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is usually needed; monitor for hematologic toxicity as part of routine pomalidomide care.

What other medicines interact with Erythromycin?

MediHelp also lists interactions of Erythromycin with, for example, Conivaptan, Dihydroergotamine intranasal, Dihydroergotamine. The full list is on the Erythromycin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in